Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2.

Tancevski I, Nairz M, Duwensee K, Auer K, Schroll A, Heim C, Feistritzer C, Hoefer J, Gerner RR, Moschen AR, Heller I, Pallweber P, Li X, Theurl M, Demetz E, Wolf AM, Wolf D, Eller P, Ritsch A, Weiss G.

EMBO Mol Med. 2014 Jun;6(6):810-20. doi: 10.1002/emmm.201303415. Epub 2014 Apr 6.

2.

Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.

Demetz E, Tancevski I, Duwensee K, Stanzl U, Huber E, Heim C, Handle F, Theurl M, Schroll A, Tailleux A, Dietrich H, Patsch JR, Eller P, Ritsch A.

Atherosclerosis. 2012 Jun;222(2):360-6. doi: 10.1016/j.atherosclerosis.2012.03.012. Epub 2012 Mar 23.

3.

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.

Duwensee K, Schwaiger S, Tancevski I, Eller K, van Eck M, Markt P, Linder T, Stanzl U, Ritsch A, Patsch JR, Schuster D, Stuppner H, Bernhard D, Eller P.

Atherosclerosis. 2011 Nov;219(1):109-15. doi: 10.1016/j.atherosclerosis.2011.07.023. Epub 2011 Jul 21.

4.

Cholesteryl ester transfer protein in patients with coronary heart disease.

Duwensee K, Breitling LP, Tancevski I, Rothenbacher D, Demetz E, Patsch JR, Ritsch A, Eller P, Brenner H.

Eur J Clin Invest. 2010 Jul;40(7):616-22. doi: 10.1111/j.1365-2362.2010.02313.x. Epub 2010 May 23.

PMID:
20497463
5.

The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice.

Tancevski I, Demetz E, Eller P, Duwensee K, Hoefer J, Heim C, Stanzl U, Wehinger A, Auer K, Karer R, Huber J, Schgoer W, Van Eck M, Vanhoutte J, Fievet C, Stellaard F, Rudling M, Patsch JR, Ritsch A.

PLoS One. 2010 Jan 15;5(1):e8722. doi: 10.1371/journal.pone.0008722.

6.

Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.

Ritsch A, Scharnagl H, Eller P, Tancevski I, Duwensee K, Demetz E, Sandhofer A, Boehm BO, Winkelmann BR, Patsch JR, März W.

Circulation. 2010 Jan 26;121(3):366-74. doi: 10.1161/CIRCULATIONAHA.109.875013. Epub 2010 Jan 11.

7.

The thyromimetic T-0681 protects from atherosclerosis.

Tancevski I, Wehinger A, Demetz E, Hoefer J, Eller P, Huber E, Stanzl U, Duwensee K, Auer K, Schgoer W, Kuhn V, Fievet C, Stellaard F, Rudling M, Foeger B, Patsch JR, Ritsch A.

J Lipid Res. 2009 May;50(5):938-44. doi: 10.1194/jlr.M800553-JLR200. Epub 2008 Dec 22.

8.

The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Eller P, Schgoer W, Mueller T, Tancevski I, Demetz E, Duwensee K, Ritsch A, Haltmayer M, Patsch JR.

Heart Vessels. 2008 Mar;23(2):104-7. doi: 10.1007/s00380-007-1014-9. Epub 2008 Apr 4.

PMID:
18389334
9.

Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Tancevski I, Wehinger A, Demetz E, Eller P, Duwensee K, Huber J, Hochegger K, Schgoer W, Fievet C, Stellaard F, Rudling M, Patsch JR, Ritsch A.

Endocrinology. 2008 Jul;149(7):3708-12. doi: 10.1210/en.2007-1387. Epub 2008 Apr 3.

Supplemental Content

Loading ...
Support Center